Peregrine to Report Financial Results for First Quarter of Fiscal Year 2016 After Market Close on September 9, 2015
September 03, 2015 16:05 ET
|
Peregrine Pharmaceuticals Inc.
TUSTIN, Calif., Sept. 03, 2015 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) (NASDAQ:PPHMP), a biopharmaceutical company focused on developing therapeutics to stimulate the...
Peregrine Pharmaceuticals Presents Data at Annual Immunotherapy and Vaccine Summit (ImVacS) Supporting Ability of Bavituximab to Mediate Anti-Tumor T Cell Responses Across Multiple Tumor Types
August 26, 2015 09:00 ET
|
Peregrine Pharmaceuticals Inc.
- Increasing Activated T Cells in Tumors Demonstrates Potential Complement to anti-PD-1 and anti-PD-L1 Checkpoint Inhibitors - - Clinical and Preclinical Studies Demonstrate Estimated Survival...
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Peregrine Pharmaceuticals, Inc.
May 17, 2010 08:30 ET
|
Crystal Research Associates, LLC
NEW YORK, NY--(Marketwire - May 17, 2010) - Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview® (EIO®) on Peregrine...